Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 299

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily

Open access
Bierhaus, Angelika, Haslbeck, Karl-Matthias, Humpert, Per M., Liliensiek, Birgit, Dehmer, Thomas, Morcos, Michael, Sayed, Ahmed A.R., Andrassy, Martin, Schiekofer, Stephan, Schneider, Jochen G., Schulz, Jörg B., Heuss, Dieter, Neundörfer, Bernhard, Dierl, Stefan, Huber, Jochen, Tritschler, Hans, Schmidt, Ann-Marie, Schwaninger, Markus, Haering, Hans-Ulrich, Schleicher, Erwin, Kasper, Michael, Stern, David M., Arnold, Bernd, Nawroth, Peter P.·2004·Journal of Clinical Investigation

Abstract

Molecular events that result in loss of pain perception are poorly understood in diabetic neuropathy. Our results show that the receptor for advanced glycation end products (RAGE), a receptor associated with sustained NF-kappaB activation in the diabetic microenvironment, has a central role in sensory neuronal dysfunction. In sural nerve biopsies, ligands of RAGE, the receptor itself, activated NF-kappaBp65, and IL-6 colocalized in the microvasculature of patients with diabetic neuropathy. Activation of NF-kappaB and NF-kappaB-dependent gene expression was upregulated in peripheral nerves of diabetic mice, induced by advanced glycation end products, and prevented by RAGE blockade. NF-kappaB activation was blunted in RAGE-null (RAGE(-/-)) mice compared with robust enhancement in strain-matched controls, even 6 months after diabetes induction. Loss of pain perception, indicative of long-standing diabetic neuropathy, was reversed in WT mice treated with soluble RAGE. Most importantly, loss of pain perception was largely prevented in RAGE(-/-) mice, although they were not protected from diabetes-induced loss of PGP9.5-positive plantar nerve fibers. These data demonstrate, for the first time to our knowledge, that the RAGE-NF-kappaB axis operates in diabetic neuropathy, by mediating functional sensory deficits, and that its inhibition may provide new therapeutic approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci18058

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 7

  1. 10.1002/(SICI)1096-9136(1998120)15:4+<s57::aid-dia741>3.3.CO;2-4</s57::aid-dia741> · doi:10.1002/(sici)1096-9136(1998120)15:4+<s57::aid-dia741>3.3.co;2-4</s57::aid-dia741>
  2. Carrington, 1999, Diabetes Reviews., 7, 275
  3. 10.1016/S0006-8993(99)01670-4 · doi:10.1016/s0006-8993(99)01670-4
  4. 10.1007/s00401-002-0518-8 · doi:10.1007/s00401-002-0518-8
  5. Schmidt, 2001, J. Clin. Invest., 108, 949, 10.1172/JCI200114002 · DOI
  6. Liliensiek, 2004, J. Clin. Invest., 113, 1641, 10.1172/JCI200418704 · DOI
  7. Neundörfer, 1998, Dtsch. Med. Wochenschr., 23, 1519, 10.1055/s-2007-1023888 · doi:10.1055/s-2007-1023888

Cited by

See all 299

Metadata

Authors
Bierhaus, A., Haslbeck, K.-M., Humpert, P. M., Liliensiek, B., Dehmer, T., Morcos, M., Sayed, A. A. R., Andrassy, M., Schiekofer, S., Schneider, J. G., Schulz, J. B., Heuss, D., Neundörfer, B., Dierl, S., Huber, J., Tritschler, H., Schmidt, A.-M., Schwaninger, M., Haering, H.-U., Schleicher, E., Kasper, M., Stern, D. M., Arnold, B., & Nawroth, P. P.
Venue
Journal of Clinical Investigation
Published
2004-12-15
Volume
114
Issue
12
Pages
1741-1751
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2162666481
Cited by
299
References
50
FWCI
10.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. https://app.cochat.ai/papers/10.1172/jci18058
The paper
Bierhaus, A., Haslbeck, K.-M., Humpert, P. M., Liliensiek, B., Dehmer, T., Morcos, M., Sayed, A. A. R., Andrassy, M., Schiekofer, S., Schneider, J. G., Schulz, J. B., Heuss, D., Neundörfer, B., Dierl, S., Huber, J., Tritschler, H., Schmidt, A.-M., Schwaninger, M., Haering, H.-U., . . . Nawroth, P. P. (2004). Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. Journal of Clinical Investigation. https://doi.org/10.1172/jci18058

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.